Alyssa K. Whitney

Alyssa K. Whitney

Auto-generated profile, based on publicly available information

Alyssa K. Whitney

Department of Internal Medicine, Mayo Clinic, Rochester, MN

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2014 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
ASAmy Sheflin
Amy Sheflin
AWAlyssa K. Whitney
Alyssa K. Whitney
TWTiffany Weir
Tiffany Weir

16 August 2017 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
KKK A Kuhn
K A Kuhn
HSH M Schulz
H M Schulz
ERE H Regner
E H Regner
ESE L Severs
E L Severs
JHJ D Hendrickson
J D Hendrickson
SCS P Colgan
S P Colgan
Interactions between the microbiota and distal gut are important for the maintenance of a healthy intestinal barrier; dysbiosis of intestinal microbial communities has emerged as a likely contributor to diseases that arise at the level of the mucosa. Intraepithelial lymphocytes (IELs) are positioned within the epithelial barrier, and in the small intestine they function to maintain epithelial homeostasis. We hypothesized that colon IELs promote epithelial barrier function through the expression of cytokines in response to interactions with commensal bacteria. Profiling of bacterial 16S ribosomal RNA revealed that candidate bacteria in the order Bacteroidales are sufficient to promote IEL presence in the colon that in turn produce interleukin-6 (IL-6) in a MyD88 (myeloid differentiation primary response 88)-dependent manner. IEL-derived IL-6 is functionally important in the maintenance of the epithelial barrier as IL-6−/− mice were noted to have increased paracellular permeability, decreased claudin-1 expression, and a thinner mucus gel layer, all of which were reversed by transfer of IL-6+/+ IELs, leading to protection of mice in response to Citrobacter rodentium infection. Therefore, we conclude that microbiota provide a homeostatic role for epithelial barrier function through regulation of IEL-derived IL-6.

12 September 2016 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
ASAmy Sheflin
Amy Sheflin
EBErica C. Borresen
Erica C. Borresen
JKJay S. Kirkwood
Jay S. Kirkwood
CBClaudia M. Boot
Claudia M. Boot
AWAlyssa K. Whitney
Alyssa K. Whitney
TWTiffany Weir
Tiffany Weir

18 August 2015 in Gut Pathogens
Verified
Journal Article
Open access
PDF file
AWAlyssa K Whitney
Alyssa K Whitney
TWTiffany Weir
Tiffany Weir
Previous studies have highlighted the antimicrobial activity of caffeine, both individually and in combination with other compounds. A proposed mechanism for caffeine’s antimicrobial effects is inhibition of bacterial DNA repair pathways. The current study examines the influence of sub-lethal caffeine levels on the growth and morphology of SOS response pathway mutants of Escherichia coli. Growth inhibition after treatment with caffeine and methyl methane sulfonate (MMS), a mutagenic agent, was determined for E. coli mutants lacking key genes in the SOS response pathway. The persistence of caffeine’s effects was explored by examining growth and morphology of caffeine and MMS-treated bacterial isolates in the absence of selective pressure. Caffeine significantly reduced growth of E. coli recA- and uvrA-mutants treated with MMS. However, there was no significant difference in growth between umuC-isolates treated with MMS alone and MMS in combination with caffeine after 48 h of incubation. When recA-isolates from each treatment group were grown in untreated medium, bacterial isolates that had been exposed to MMS or MMS with caffeine showed increased growth relative to controls and caffeine-treated isolates. Morphologically, recA-isolates that had been treated with caffeine and both caffeine and MMS together had begun to display filamentous growth. Caffeine treatment further reduced growth of recA- and uvrA-mutants treated with MMS, despite a non-functional SOS response pathway. However, addition of caffeine had very little effect on MMS inhibition of umuC-mutants. Thus, growth inhibition of E. coli with caffeine treatment may be driven by caffeine interaction with UmuC, but also appears to induce damage by additional mechanisms as evidenced by the additive effects of caffeine in recA- and uvrA-mutants.

25 March 2021 in Microbiology Resource Announcements
Verified
Journal Article
Open access
PDF file
AMAlyssa K. W. Maclean
Alyssa K. W. Maclean
NHNancy D. Hanson
Nancy D. Hanson
Klebsiella pneumoniae strains are capable of becoming resistant through multiple mechanisms. Here, we announce draft sequences for Kp 23, a clinical isolate with no plasmid-encoded β-lactamases, and KPM 20, a clinical isolate with no plasmid-encoded β-lactamases and no detectable OmpK35, OmpK36, or PhoE in the outer membrane.

1 June 2016
Verified
Book Chapter
Closed access
PDF file
AWAlyssa K. Whitney
Alyssa K. Whitney
ECEric L. Campbell
Eric L. Campbell